Want to track GOSS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gossamer Bio Inc. (GOSS) Statistics
Valuation metrics
Market Cap 86.82M
Enterprise value 73.34M
Trailing P/E (ttm) -0.27
Forward P/E -2.04
PEG ratio 0.14
Price/Sales (ttm) 1.41
Price/Book (mrq) -0.52
Enterprise Value/Revenue 1.38
Enterprise Value/EBITDA -0.46
Overview
Shares outstanding 233.68M
Float 212.01M
Shares short 40.02M
% Held by insiders 0.04%
% Held by institutions 0.72%
Average volume (10 days) 13.56M
Average volume (90 days) 53.27M
Price summary
52-Week low 0.11
52-Week high 3.87
Beta 2.15
50-Day moving average 0.17
200-Day moving average 0.73
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.35%
Operating margin -3.12%
Operational effectiveness
Return on assets -1.63%
Return on equity 1.09%
Income Statement
Revenue (ttm) 48.47M
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) 0.47%
Gross profit (ttm) 48.47M
EBITDA -163.23M
Net income to common (ttm) -170.37M
Diluted EPS (ttm) -0.39
Quarterly earnings growth (yoy) 0.47%
Balance Sheet
Total cash (mrq) 136.93M
Total cash per share (mrq) 0.18
Total debt (mrq) 202.91M
Total Debt/Equity (mrq) -0.42
Current ratio (mrq) 0.53%
Book value per share (mrq) -0.29
Cash Flow
Cash flow statement -171.27M
Levered free cash flow (LFCF) -93.33M
